Analysed ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) News Sources
Allarity Therapeutics Advances Stenoparib Toward Pivotal Development with Phase 3 Manufacturing Campaign
05-05-2026
yahoo.com
Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm
08-05-2026
yahoo.com
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
15-05-2026
yahoo.com
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
18-06-2026
yahoo.com
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?
19-06-2026
yahoo.com
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
30-06-2026
yahoo.com
Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?
06-07-2026
yahoo.com
What is the current price of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?
The current price of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is $1.165.
ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) since the previous trading day is $-0.035.
ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) since the previous trading day is -2.9167%.
What is the most recent average sentiment score for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?
The most recent average sentiment score for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)?
The most recent sentiment for ALLARITY THERAPEUTICS INC (ALLR:NASDAQ) is .
SEC-8K** Filing Available For ALLARITY THERAPEUTICS INC (ALLR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.